Business Context and Reporting Period
PainReform Ltd. (PRF Technologies Ltd.) filed a Form 6-K on November 18, 2024, for the month of November 2024. The registrant is a foreign private issuer based in Tel Aviv, Israel, reporting under Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding share capital structure.
Material Changes
The Company announced a 1-for-4 reverse share split effective after market close on Wednesday, November 20, 2024. Key details include:
- Split Ratio: Four (4) ordinary shares will be consolidated into one (1) ordinary share.
- Trading Resumption: Shares will begin trading on the Nasdaq Capital Market on Thursday, November 21, 2024.
- Authorized Capital: Post-split authorized share capital will be 2,500,000 ordinary shares.
- Outstanding Shares: Approximately 590,616 ordinary shares will be issued and outstanding following the split.
- Fractional Shares: No fractional shares will be issued; all fractions will be rounded up to the nearest whole share.
- Derivatives: Proportionate adjustments will be made to the exercise price and share count for all outstanding options and warrants.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the mechanics of the reverse split. No unusual items were reported.
Investor Verification Checklist
- Confirm the exact number of shares held post-split, noting the rounding up of fractional shares.
- Verify the adjusted exercise price and share count for any held options or warrants.
- Monitor trading activity on the Nasdaq Capital Market starting November 21, 2024.
- Review the updated authorized share capital limit of 2,500,000 shares.